Veridex was the first company to create rare cell technology, and our proven track record of innovation continues. In 2009, the technology that measures circulating tumor cells in the CELLSEARCH® system was honored with a Prix Galien USA Award for Best Medical Technology. And the Cleveland Clinic, a leading multispecialty academic medical center, ranked it as the top medical innovation.
What makes CELLSEARCH® so exceptional? The technology is remarkably flexible. We can change the capture mechanism, ferrofluid reagent, to capture and detect many different kinds of rare cells. And we can change assays with numerous staining reagents and markers, and develop a customized assay to meet your exact specifications.
From collection to capture to analysis, our exceptionally versatile CELLSEARCH® technology standardizes and elevates your whole development process.
This site is published by Veridex, LLC, which is solely responsible for its contents. © Veridex, LLC 2011. This site is intended for use by residents of the United States of America.
This information is intended for biotech, pharmaceutical, and/or academic researchers. The products/services discussed are for research use only and not for use in diagnostic
procedures. Last updated on: 22 April 2013